In recent years, endoscopically placed endoprosthesis has become an alternative to traditional operative biliary-digestive bypass in palliative treatment of patients with non-resectable biliary obstruction caused by malignant stricture of the extrahepatic bile duct. In an uncontrolled series the endoscopic approach has been recommended as the treatment of choice.' Alternatively surgery has been recommended primarily because 13% of the survivors needed a later operation for duodenal obstruction.2 The combined intraoperative and postoperative mortality (30 days mortality) after bypass surgery is reported to be 15-30%,2 and the corresponding mortality for the endoscopic approach 10-18%.'3 The procedure related mortality of endoprosthesis insertion was low (0-2%),' and success rates in the application of the stent were high (90%).' Sonnenfeld et al' reported a non-randomised comparison of endoprosthesis versus bypass with 20 patients in each group and found no difference in survival, but the
prosthesis is as effective as operative bypass.
In recent years, endoscopically placed endoprosthesis has become an alternative to traditional operative biliary-digestive bypass in palliative treatment of patients with non-resectable biliary obstruction caused by malignant stricture of the extrahepatic bile duct. In an uncontrolled series the endoscopic approach has been recommended as the treatment of choice.' Alternatively surgery has been recommended primarily because 13% of the survivors needed a later operation for duodenal obstruction. 2 The combined intraoperative and postoperative mortality (30 days mortality) after bypass surgery is reported to be 15-30%,2 and the corresponding mortality for the endoscopic approach 10-18%. '3 The procedure related mortality of endoprosthesis insertion was low (0-2%),' and success rates in the application of the stent were high (90%).' Sonnenfeld et al' reported a non-randomised comparison of endoprosthesis versus bypass with 20 patients in each group and found no difference in survival, but the hospitalisation time was longer and major complications were more frequent in the operated group During the initial endoscopy patients were randomised by means of sealed envelopes to endoscopical treatment with 7 or 10 French endoprosthesis or to treatment with bypass surgery (Table  2 ). Twenty two patients had their endoprosthesis inserted at the time of randomisation; three patients had the endoscopy repeated with a delay of median three days, range two to four days, before the stent Table 2 Typ)es of oper-ation performed in 19 patients wit/i bile duct occlusion as a r-esult of malignant disease C'holecysto-jejullostomy 13 C holedocho-jejunostomy 3 Choledocho-duodenostomy 3 Supplementary gastro-enterostomy 4 could be placed. The therapeutic delay in the operation group was median 1 day, range 0-17 days. No prophylactic antibiotics were used. The initial treatment was considered successful if the serum bilirubin dropped to less than 5()% of the initial value, if not patients were treated as the alternative group. Every patient was seen in the outpatient clinic every 100 days until death. An estimate of the patients' quality of life was performed at every control visit by the investigators, ranking the patients' degree of immobilisation in five groups: normal, limited but no need for aid for basic activities, limited with need for aid, bedridden, and massive aid needed. The percentage of survival time the individual spent in the various selfcare ability groups was calculated from this information.
Patients gave informed consent and had the chance to change the treatment at any time during the course of their disease. As mentioned above two patients used this option. The consent was given before the ERCP: if the investigator judged that both endoprosthesis, and operation was equally favourable for the patient, then randomisation was performed. Information about the malignant diagnosis was given after the investigation, and the patient had the opportunity to reconsider the decision. The The 25 patients randomised to endoscopic treatment were hospitalised for a median of 26 days (range 3-210) which constituted median 26% (3-100) of their survival time. The corresponding figures for the 25 patients randomised to operation were 27 days (10-202), or 54% (2-100) of the survival time. These differences were not significantly different. When analysed according to the treatment applied, the difference was still not significant. In the endoscopy group seven patients were never discharged from the hospital compared with seven patients in the operated group. 
QUALITY OF LIFE
An estimate of the patients quality of life is shown in Table 4 . No significant differences were revealed, neither considering randomisation groups, nor when patients were grouped according to the treatment applied.
Discussion
Scientifically based guidance is poor as to the method of choice for palliation of obstructive jaundice in nonresectable malignant disease. Two randomised studies have previously been published. Speer et a!" showed that the endoscopic route for introduction of an endoprosthesis was significantly better than the percutaneous transhepatic route. As in the present investigation they evaluated their results according to the principle of intention of treat; the only reliable method if the question of a future routine procedure is to be answered. In a similar trial including younger patients (mean age 62 years) Bornman et al. found no differences in survival, complication rates or duration of hospitalisation between percutaneous transhepatic endoprosthesis and bypass surgery. Hospitalisation for terminal care, however, was not included in the analysis. The present investigation is the third randomised trial and the first study comparing endoscopic endoprosthesis to bypass surgery. The results are almost identical in the two treatment groups, whether evaluated according to the intention to treat principle, or according to the treatment applied. One might have expected a shorter hospitalisation time in the endoscopically treated patients, but the need for changing the stent in some patients and the slightly higher rate of cholangitis balanced the longer initial hospitalisation time in the operated group. Additionally, the large fraction of patients that were never discharged from hospital tended to blur any minor difference. We experienced no failures as to insertion of the endoprosthesis. Success rates of 89% and 90%' have been reported. These figures indicate that the published results are from centres with considerable experience and might be valid for such centres only. Duodenal obstruction have occurred in 7-5%,' 13%, 14%, and 3%h in published data comparable with the present. None of our patients developed duodenal obstruction, and nor did any of the patients in other investigations on endoscopically placed stents.."' The explanation might well be that patients with an incomplete duodenal obstruction have not been included in these studies as the obstruction prevented the initial ERCP. The survival time in the present study is compatible with those previously reported,'-and probably reflected the spontaneous course of the malignant disease rather than treatment results.
We conclude that if the routine procedure for diagnosing the cause of obstructive jaundice in a hospital is ERCP and if the potential for stent insertion is present, then endoscopically introduced endoprosthesis seems to be as beneficial as operative treatment for palliation of malignant biliary obstruction. 
